001448491 000__ 03067cam\a2200493\a\4500
001448491 001__ 1448491
001448491 003__ OCoLC
001448491 005__ 20230310004241.0
001448491 006__ m\\\\\o\\d\\\\\\\\
001448491 007__ cr\un\nnnunnun
001448491 008__ 220806s2022\\\\si\\\\\\o\\\\\000\0\eng\d
001448491 019__ $$a1337856446
001448491 020__ $$a9789811926150$$q(electronic bk.)
001448491 020__ $$a9811926158$$q(electronic bk.)
001448491 020__ $$z981192614X
001448491 020__ $$z9789811926143
001448491 0247_ $$a10.1007/978-981-19-2615-0$$2doi
001448491 035__ $$aSP(OCoLC)1337944361
001448491 040__ $$aEBLCP$$beng$$epn$$cEBLCP$$dGW5XE$$dYDX$$dEBLCP$$dOCLCQ
001448491 049__ $$aISEA
001448491 050_4 $$aRC848.C5
001448491 08204 $$a616.3/624$$223/eng/20220809
001448491 24500 $$aPharmacotherapy for liver cirrhosis and its complications /$$cXingshun Qi, Yongping Yang, editors.
001448491 260__ $$aSingapore :$$bSpringer,$$c2022.
001448491 300__ $$a1 online resource (245 pages)
001448491 336__ $$atext$$btxt$$2rdacontent
001448491 337__ $$acomputer$$bc$$2rdamedia
001448491 338__ $$aonline resource$$bcr$$2rdacarrier
001448491 5050_ $$aAnti-HBV drugs in liver cirrhosis -- Anti-HCV drugs in liver cirrhosis -- Anticoagulants in liver cirrhosis -- Antibiotics in liver cirrhosis -- Silymarin in liver cirrhosis -- Ursodeoxycholic acid in liver cirrhosis -- Emricasan in liver cirrhosis -- Non-selective beta blockers in liver cirrhosis -- Somatostatin and octreotide in liver cirrhosis -- Terlipressin in liver cirrhosis -- Diuretics in liver cirrhosis -- Statins in liver cirrhosis -- L-Ornithine L-Aspartate in liver cirrhosis -- Lactulose in liver cirrhosis.
001448491 506__ $$aAccess limited to authorized users.
001448491 520__ $$aThis book aims to provide an updated information on different types of major and emerging drugs for managing liver cirrhosis and its complications, including acute gastroesophageal variceal bleeding, ascites, hepatic encephalopathy, liver failure, acute kidney injury, and portal venous thrombosis. The chapters are organized by drug class, such as anti-HBV drugs, anti-HCV drugs, anticoagulants, and antibiotics, etc. The clinical efficacy, indication, and contra-indication of the various drug therapies are discussed using supportive reference material from authoritative sources and published clinical trials. It will be an invaluable reference for physicians who are treating patients with liver cirrhosis, especially those presenting with acute life-threatening complications.
001448491 588__ $$aOnline resource; title from PDF title page (SpringerLink, viewed August 9, 2022).
001448491 650_0 $$aLiver$$xCirrhosis$$xChemotherapy.
001448491 650_0 $$aLiver$$xCirrhosis$$xChemotherapy$$xComplications.
001448491 655_0 $$aElectronic books.
001448491 7001_ $$aQi, Xingshun,$$d1984-
001448491 7001_ $$aYang, Yongping.
001448491 77608 $$iPrint version:$$aQi, Xingshun.$$tPharmacotherapy for Liver Cirrhosis and Its Complications.$$dSingapore : Springer, ©2022$$z9789811926143
001448491 852__ $$bebk
001448491 85640 $$3Springer Nature$$uhttps://univsouthin.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-981-19-2615-0$$zOnline Access$$91397441.1
001448491 909CO $$ooai:library.usi.edu:1448491$$pGLOBAL_SET
001448491 980__ $$aBIB
001448491 980__ $$aEBOOK
001448491 982__ $$aEbook
001448491 983__ $$aOnline
001448491 994__ $$a92$$bISE